Mitochondrial DNA copy number is associated with breast cancer risk
- PMID: 23776581
- PMCID: PMC3680391
- DOI: 10.1371/journal.pone.0065968
Mitochondrial DNA copy number is associated with breast cancer risk
Abstract
Mitochondrial DNA (mtDNA) copy number in peripheral blood is associated with increased risk of several cancers. However, data from prospective studies on mtDNA copy number and breast cancer risk are lacking. We evaluated the association between mtDNA copy number in peripheral blood and breast cancer risk in a nested case-control study of 183 breast cancer cases with pre-diagnostic blood samples and 529 individually matched controls among participants of the Singapore Chinese Health Study. The mtDNA copy number was measured using real time PCR. Conditional logistic regression analyses showed that there was an overall positive association between mtDNA copy number and breast cancer risk (P(trend) = 0.01). The elevated risk for higher mtDNA copy numbers was primarily seen for women with <3 years between blood draw and cancer diagnosis; ORs (95% CIs) for 2(nd), 3(rd), 4(th), and 5(th) quintile of mtDNA copy number were 1.52 (0.61, 3.82), 2.52 (1.03, 6.12), 3.12 (1.31, 7.43), and 3.06 (1.25, 7.47), respectively, compared with the 1(st) quintile (P(trend) = 0.004). There was no association between mtDNA copy number and breast cancer risk among women who donated a blood sample ≥3 years before breast cancer diagnosis (P(trend) = 0.41). This study supports a prospective association between increased mtDNA copy number and breast cancer risk that is dependent on the time interval between blood collection and breast cancer diagnosis. Future studies are warranted to confirm these findings and to elucidate the biological role of mtDNA copy number in breast cancer risk.
Conflict of interest statement
Similar articles
-
Mitochondrial DNA Copy Number in Peripheral Blood Cells and Risk of Developing Breast Cancer.Cancer Res. 2015 Jul 15;75(14):2844-50. doi: 10.1158/0008-5472.CAN-14-1692. Epub 2015 May 14. Cancer Res. 2015. PMID: 25977328
-
Mitochondrial DNA copy number and future risk of B-cell lymphoma in a nested case-control study in the prospective EPIC cohort.Blood. 2014 Jul 24;124(4):530-5. doi: 10.1182/blood-2013-10-532085. Epub 2014 Jun 4. Blood. 2014. PMID: 24899624 Free PMC article.
-
Peripheral blood mitochondrial DNA copy number is associated with prostate cancer risk and tumor burden.PLoS One. 2014 Oct 3;9(10):e109470. doi: 10.1371/journal.pone.0109470. eCollection 2014. PLoS One. 2014. PMID: 25279731 Free PMC article.
-
Mitochondrial DNA copy number variation, leukocyte telomere length, and breast cancer risk in the European Prospective Investigation into Cancer and Nutrition (EPIC) study.Breast Cancer Res. 2018 Apr 17;20(1):29. doi: 10.1186/s13058-018-0955-5. Breast Cancer Res. 2018. PMID: 29665866 Free PMC article.
-
Mitochondrial copy number is associated with colorectal cancer risk.Cancer Epidemiol Biomarkers Prev. 2012 Sep;21(9):1574-81. doi: 10.1158/1055-9965.EPI-12-0138-T. Epub 2012 Jul 11. Cancer Epidemiol Biomarkers Prev. 2012. PMID: 22787200 Free PMC article.
Cited by
-
Deregulation of mitochondrial gene expression in cancer: mechanisms and therapeutic opportunities.Br J Cancer. 2024 Aug 14. doi: 10.1038/s41416-024-02817-1. Online ahead of print. Br J Cancer. 2024. PMID: 39143326 Review.
-
Mitochondrial DNA copy number and risk of papillary thyroid carcinoma.BMC Endocr Disord. 2024 Aug 2;24(1):138. doi: 10.1186/s12902-024-01669-3. BMC Endocr Disord. 2024. PMID: 39090709 Free PMC article.
-
Higher peripheral blood mitochondrial DNA copy number and relative telomere length in under 48 years Indonesian breast cancer patients.BMC Res Notes. 2024 Apr 28;17(1):120. doi: 10.1186/s13104-024-06783-y. BMC Res Notes. 2024. PMID: 38679744 Free PMC article.
-
Profiling mitochondrial DNA mutations in tumors and circulating extracellular vesicles of triple-negative breast cancer patients for potential biomarker development.FASEB Bioadv. 2023 Sep 8;5(10):412-426. doi: 10.1096/fba.2023-00070. eCollection 2023 Oct. FASEB Bioadv. 2023. PMID: 37810173 Free PMC article.
-
Oxygen levels at the time of activation determine T cell persistence and immunotherapeutic efficacy.Elife. 2023 May 11;12:e84280. doi: 10.7554/eLife.84280. Elife. 2023. PMID: 37166103 Free PMC article.
References
-
- Society AC (2012) Cancer Facts & Figures 2012. Atlanta: American Cancer Society.
-
- Bray F, Jemal A, Grey N, Ferlay J, Forman D (2012) Global cancer transitions according to the Human Development Index (2008–2030): a population-based study. Lancet Oncol 13: 790–801. - PubMed
-
- Lee HC, Wei YH (2005) Mitochondrial biogenesis and mitochondrial DNA maintenance of mammalian cells under oxidative stress. Int J Biochem Cell Biol 37: 822–834. - PubMed
-
- Fernandez-Silva P, Enriquez JA, Montoya J (2003) Replication and transcription of mammalian mitochondrial DNA. Exp Physiol 88: 41–56. - PubMed
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Miscellaneous